benzethonium chloride 0.0015 MG/MG / diphenhydramine hydrochloride 0.02 MG/MG / zinc acetate 0.00215 MG/MG Topical Gel [Calagel]

RxCUI
1049176
RxNorm name
benzethonium chloride 0.0015 MG/MG / diphenhydramine hydrochloride 0.02 MG/MG / zinc acetate 0.00215 MG/MG Topical Gel [Calagel]
Display name
CALAGEL (Topical)
Full name
benzethonium chloride 0.0015 MG/MG / diphenhydramine hydrochloride 0.02 MG/MG / zinc acetate 0.00215 MG/MG Topical Gel [Calagel]
Term type
SBD
Status
Active
Strength
0.15-2-0.215%
Dose form
Gel
Route
Topical
Updated
2026-07-25 06:52:49

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012011
Active start
012011
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
benzethonium chloride0.0015 MG / 1 MGbenzethoniumbenzethonium chloride
diphenhydramine hydrochloride0.02 MG / 1 MGdiphenhydraminediphenhydramine hydrochloride
zinc acetate0.00215 MG / 1 MGzinc acetatezinc acetate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Gel346286

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzethonium1390
diphenhydramine3498
zinc acetate58295

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
51879080006rxnav_ndcsyes
51879080016rxnav_historical
51879080044rxnav_historical
51879080066rxnav_historical

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCR06AAAminoalkyl ethersATC1-4diphenhydramine
ATCD04AAAntihistamines for topical useATC1-4diphenhydramine
ATCR02AAAntisepticsATC1-4benzethonium
ATCD08AJQuaternary ammonium compoundsATC1-4benzethonium chloride
ATCA16AXVarious alimentary tract and metabolism productsATC1-4zinc acetate
FDASPLN0000175587Histamine-1 Receptor AntagonistEPChas_epcdiphenhydramine
FDASPLN0000000190Histamine H1 Receptor AntagonistsMOAhas_moadiphenhydramine
MEDRTD001558BenzethoniumCHEMhas_ingredientbenzethonium
MEDRTD001558BenzethoniumCHEMhas_ingredientbenzethonium chloride
MEDRTD004155DiphenhydramineCHEMhas_ingredientdiphenhydramine hydrochloride
MEDRTD004155DiphenhydramineCHEMhas_ingredientdiphenhydramine
MEDRTD019345Zinc AcetateCHEMhas_ingredientzinc acetate
MEDRTD001008Anxiety DisordersDISEASEmay_treatdiphenhydramine
MEDRTD001008Anxiety DisordersDISEASEmay_treatdiphenhydramine hydrochloride
MEDRTD003139Common ColdDISEASEmay_treatzinc acetate
MEDRTD004342Drug HypersensitivityDISEASEci_withdiphenhydramine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withdiphenhydramine
MEDRTD007231Infant, NewbornDISEASEci_withdiphenhydramine hydrochloride
MEDRTD007231Infant, NewbornDISEASEci_withdiphenhydramine
MEDRTD007234Infant, PrematureDISEASEci_withdiphenhydramine hydrochloride
MEDRTD007234Infant, PrematureDISEASEci_withdiphenhydramine
MEDRTD007774LactationDISEASEci_withdiphenhydramine
MEDRTD007774LactationDISEASEci_withdiphenhydramine hydrochloride
MEDRTD009041Motion SicknessDISEASEmay_treatdiphenhydramine
MEDRTD009041Motion SicknessDISEASEmay_treatdiphenhydramine hydrochloride
MEDRTD009325NauseaDISEASEmay_treatdiphenhydramine
MEDRTD009325NauseaDISEASEmay_treatdiphenhydramine hydrochloride
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatdiphenhydramine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatdiphenhydramine hydrochloride
MEDRTD012883Skin UlcerDISEASEmay_treatzinc acetate
MEDRTD007319Sleep Initiation and Maintenance DisordersDISEASEmay_treatdiphenhydramine hydrochloride
MEDRTD007319Sleep Initiation and Maintenance DisordersDISEASEmay_treatdiphenhydramine
MEDRTD012912SneezingDISEASEmay_treatdiphenhydramine hydrochloride
MEDRTD012912SneezingDISEASEmay_treatdiphenhydramine
MEDRTD013224Status AsthmaticusDISEASEci_withdiphenhydramine hydrochloride
MEDRTD013224Status AsthmaticusDISEASEci_withdiphenhydramine
MEDRTD014581UrticariaDISEASEmay_treatdiphenhydramine hydrochloride
MEDRTD014581UrticariaDISEASEmay_treatdiphenhydramine
MEDRTD014947Wounds and InjuriesDISEASEmay_treatzinc acetate
MEDRTN0000000226Acid-Base ActivityMOAhas_moazinc acetate
MEDRTN0000000220Electrolyte ActivityMOAhas_moazinc acetate
MEDRTN0000000163Enzyme InteractionsMOAhas_moazinc acetate
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moadiphenhydramine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moadiphenhydramine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.0015 MG/MG / 0.02 MG/MG / 0.00215 MG/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSBD
CODESRxCUI1049176
NAMESPrescribable SynonymCalagel 0.15 % / 2 % / 0.215 % Topical Gel
NAMESRXNAV_STRCalagel (benzethonium chloride 0.15 % / diphenhydrAMINE hydrochloride 2 % / zinc acetate 0.215 % ) Topical Gel
NAMESRxNorm Namebenzethonium chloride 0.0015 MG/MG / diphenhydramine hydrochloride 0.02 MG/MG / zinc acetate 0.00215 MG/MG Topical Gel [Calagel]
NAMESRxNorm SynonymCalagel (benzethonium chloride 0.0015 MG/MG / diphenhydramine hydrochloride 0.02 MG/MG / zinc acetate 0.00215 MG/MG) Topical Gel
NAMESRxNorm SynonymCalagel (benzethonium chloride 0.15 % / diphenhydramine hydrochloride 2 % / zinc acetate 0.215 % ) Topical Gel
NAMESTallman Synonymbenzethonium chloride 0.0015 MG/MG / diphenhydrAMINE hydrochloride 0.02 MG/MG / zinc acetate 0.00215 MG/MG Topical Gel [Calagel]
NAMESTallman SynonymCalagel (benzethonium chloride 0.0015 MG/MG / diphenhydrAMINE hydrochloride 0.02 MG/MG / zinc acetate 0.00215 MG/MG) Topical Gel
NAMESTallman SynonymCalagel (benzethonium chloride 0.15 % / diphenhydrAMINE hydrochloride 2 % / zinc acetate 0.215 % ) Topical Gel
SOURCESSourceGold Standard Alchemy